Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Stephen John Carter Insider Profile
4 Followers
Stephen John Carter, Chief Executive Officer at Arovella Therapeutics Limited, holds 18.09M shares in Arovella Therapeutics Limited (Ticker: AU:ALA). Most recently, Stephen John Carter Bought AU$4,522,222 shares of Arovella Therapeutics Limited on Jun 28, 2019 for an estimated value of 18.09K.
Stephen John Carter Arovella Therapeutics Limited (ALA)Chief Executive Officer
Arovella Therapeutics Limited (ALA)
Chief Executive Officer
Ranked #78,864 out of 98,909 Corporate Insiders
Profitable Transactions
0 out of 2 Profitable Transactions
Average Return
-40.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Stephen John Carter's holdings
Insider Roles
Chief Executive Officer
Roles that Stephen John Carter holds in companies
Most Profitable Insider Trade
Stock:
Rating:Informative Buy
Date:Nov 17, 2017 - Nov 17, 2018
Return:-39.40%
The most profitable trade made by Stephen John Carter
Stephen John Carter's Trading History
List of latest transactions for each holding click on a transaction to see Stephen John Carter's performance on stock
You May Also Like
Stephen John Carter insider profile FAQ
What is the percentage of profitable transactions made by Stephen John Carter?
The percentage of profitable transactions made by Stephen John Carter is 0%.
What is the average return per transaction made by Stephen John Carter?
The average return per transaction made by Stephen John Carter is -40.90%.
What stocks does Stephen John Carter hold?
Stephen John Carter holds: AU:ALA stocks.
What was Stephen John Carter’s latest transaction?
Stephen John Carter latest transaction was an Informative Buy of AU$18.09K.
What was Stephen John Carter's most profitable transaction?
Stephen John Carter’s most profitable transaction was an Informative Buy of AU:ALA stock on November 17, 2017. The return on the trade was -39.40%.
What is Stephen John Carter's role in Arovella Therapeutics Limited?
Stephen John Carter's role in Arovella Therapeutics Limited is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.